Compare BridgeBio Pharma Inc (BBIO) vs Canadian Natural Resources Ltd. (CNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Canadian Natural Resources Ltd. — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Canadian Natural Resources Ltd. trades at $47.61 (market cap $98.11B). The key difference: Canadian Natural Resources Ltd. is far larger — about 6× BridgeBio Pharma Inc's market cap, and Canadian Natural Resources Ltd. pays a 3.73% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | CNQ | |
|---|---|---|
Market Cap | $16.36B | $98.11B |
Sector | Health | Energy |
52-Week High | $90.17 | $50.55 |
52-Week Low | $47.29 | $29.31 |
Enterprise Value | $18.14B | $108.54B |
Dividend Yield | — | 3.73% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Canadian Natural Resources Ltd.
Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.
Read more on CNQ →
